New Key Statistics Module, Z-Score and F-Score
SZSE:300439 Key Ratios
Market Cap ¥ M | 3,612.97 |
Enterprise Value ¥ M | 2,789.09 |
P/E(ttm) | 13.62 |
PE Ratio without NRI | 13.78 |
Forward PE Ratio | -- |
Price/Book | 1.29 |
Price/Sales | 1.90 |
Price/Free Cash Flow | 14.29 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.15 |
Revenue (TTM) ¥ M | 1,876.00 |
EPS (TTM) ¥ | 0.69 |
Beneish M-Score | -3.2 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 35.50 |
EV-to-EBIT | 8.86 |
EV-to-EBITDA | 8.86 |
PEG | -- |
Shares Outstanding M | 383.95 |
Net Margin (%) | 14.08 |
Operating Margin % | 14.00 |
Pre-tax Margin (%) | 16.28 |
Quick Ratio | 2.70 |
Current Ratio | 3.11 |
ROA % (ttm) | 7.56 |
ROE % (ttm) | 9.83 |
ROIC % (ttm) | 11.23 |
Dividend Yield % | 1.43 |
Altman Z-Score | 5.04 |
SZSE:300439 Number of Guru Trades
SZSE:300439 Volume of Guru Trades
Gurus Latest Trades with SZSE:300439
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300439 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Medicalsystem Biotechnology Co Ltd Insider Transactions
No Available Data